Ymmunobio
PrivateLast Round
Grant
Jan 23, 2025
Total Funding Raised
$1.93M
Company Overview
Ymmunobio is a drug discovery company developing first-in-class antibody-based therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ymmunobio Comparables
Compare Ymmunobio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gilead Sciences | 81% | |
| Taiho Pharmaceutical Co., Ltd. | 77% | |
| Sotio | 77% |
Ymmunobio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 23, 2025 | ||||
| Seed | Nov 13, 2023 |
Key People
Founding team and executive leadership
Ymmunobio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKG Capital | Seed |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2025
$525K grant received from Innosuisse.
- Nov 13, 2023
$1.4M round led by OKG Capital
Ymmunobio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ymmunobio's valuation, stock price, and market status.
Is Ymmunobio a public or private company?
Ymmunobio is a private company.
What is the current stock price of Ymmunobio?
Ymmunobio is a private company with no public stock price. No recent secondary market data is available.
How much is Ymmunobio worth (valuation)?
Valuation information for Ymmunobio is not publicly available.
Can I buy Ymmunobio stock?
Ymmunobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ymmunobio's last funding round?
Ymmunobio's most recent funding round was Grant on January 23, 2025.
Who are the main investors in Ymmunobio?
Key investors in Ymmunobio include OKG Capital, Innosuisse.
Will Ymmunobio IPO soon?
No public IPO plans have been announced for Ymmunobio.
How can I track Ymmunobio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ymmunobio's secondary market activity and sign up for updates.